Cargando…

The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies

There is an urgent need for effective countermeasures against the current emergence and accelerating expansion of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Induction of herd immunity by mass vaccination has been a very successful str...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frederiksen, Lea Skak Filtenborg, Zhang, Yibang, Foged, Camilla, Thakur, Aneesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385234/ https://www.ncbi.nlm.nih.gov/pubmed/32793245 http://dx.doi.org/10.3389/fimmu.2020.01817

Ejemplares similares

Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects
por: Xu, You, et al.
Publicado: (2021)

Intrapulmonary (i.pulmon.) Pull Immunization With the Tuberculosis Subunit Vaccine Candidate H56/CAF01 After Intramuscular (i.m.) Priming Elicits a Distinct Innate Myeloid Response and Activation of Antigen-Presenting Cells Than i.m. or i.pulmon. Prime Immunization Alone
por: Thakur, Aneesh, et al.
Publicado: (2020)

Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization
por: Thakur, Aneesh, et al.
Publicado: (2018)

Nanoparticles for mucosal vaccine delivery
por: Thakur, Aneesh, et al.
Publicado: (2020)

Herd Immunity to Ebolaviruses Is Not a Realistic Target for Current Vaccination Strategies
por: Masterson, Stuart G., et al.
Publicado: (2018)

Viral Neoliberalism: The Road to Herd Immunity Still A Rocky One
por: Holst, Jens
Publicado: (2022)

Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
por: Vignesh, Ramachandran, et al.
Publicado: (2020)

Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
por: KWOK, Kin On, et al.
Publicado: (2021)

Road to achieving COVID‐19 herd immunity in Niger Republic: Challenges and recommendations
por: Abdou, Sil‐Ana Salissou, et al.
Publicado: (2022)

Herd Immunity to Fight Against COVID-19: A Narrative Review
por: Suryawanshi, Yasha N, et al.
Publicado: (2023)

Predicting the Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: The Long and Winding Road toward Validated Immune Biomarkers
por: Forcina, A., et al.
Publicado: (2013)

Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
por: Wadhwa, Abishek, et al.
Publicado: (2020)

Network models to evaluate vaccine strategies towards herd immunity in COVID-19
por: Tetteh, Josephine N.A., et al.
Publicado: (2021)

Herd immunity confusion
por: Medley, Graham F
Publicado: (2020)

Social Herd Immunity
por: Link, Denise
Publicado: (2020)

Nanoparticle Platforms for Antigen-Specific Immune Tolerance
por: Thorp, Edward B., et al.
Publicado: (2020)

Editorial: Immune dysfunction in nephrotic syndrome - recent advances and new roads ahead
por: Seitz-Polski, Barbara, et al.
Publicado: (2022)

COVID-19 herd immunity by immunisation: are children in the herd?
por: Obaro, Stephen
Publicado: (2021)

Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles
por: Lokras, Abhijeet, et al.
Publicado: (2021)

A history of herd immunity
por: Jones, David, et al.
Publicado: (2020)

Herd immunity for COVID-19
por: Burki, Talha Khan
Publicado: (2021)

Herd immunity: Deadly or defensive
por: Khan, Sameena, et al.
Publicado: (2021)

Iceland targets herd immunity
por: Wilson, Clare
Publicado: (2022)

A New In Vivo Model to Study Protective Immunity to Zika Virus Infection in Mice With Intact Type I Interferon Signaling
por: Nazerai, Loulieta, et al.
Publicado: (2018)

A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors
por: Tobias, Joshua, et al.
Publicado: (2020)

Herd immunity or suppression strategy to combat COVID-19
por: Jung, F., et al.
Publicado: (2020)

Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies
por: Thakur, Aneesh, et al.
Publicado: (2019)

In vivo Imaging Technologies to Monitor the Immune System
por: McCarthy, Claire E., et al.
Publicado: (2020)

“Don’t Look Up” Your Science—Herd Immunity or Herd Mentality?
por: Igyártó, Botond Z.
Publicado: (2022)

Was the evolutionary road towards adaptive immunity paved with endothelium?
por: van Niekerk, Gustav, et al.
Publicado: (2015)

The role of herd immunity in control of measles.
por: Black, F. L.
Publicado: (1982)

Pandemic Dynamics and the Breakdown of Herd Immunity
por: Katriel, Guy, et al.
Publicado: (2010)

Coronavirus herd immunity optimizer (CHIO)
por: Al-Betar, Mohammed Azmi, et al.
Publicado: (2020)

Herd Immunity: Understanding COVID-19
por: Randolph, Haley E., et al.
Publicado: (2020)

Has Spain reached herd immunity?
por: Kirby, Tony
Publicado: (2021)

Can Africa achieve herd immunity?
por: Lucero-Prisno, Don Eliseo, et al.
Publicado: (2021)

Achieving herd immunity in South America
por: Lucero-Prisno, Don Eliseo, et al.
Publicado: (2023)

COVID-19, Herd Immunity and Vaccine
por: Tin, Sim Sai, et al.
Publicado: (2023)

Herd immunity, vaccination and moral obligation
por: Bullen, Matthew, et al.
Publicado: (2023)

Dendritic Cell Plasticity in Tumor-Conditioned Skin: CD14(+) Cells at the Cross-Roads of Immune Activation and Suppression
por: van de Ven, Rieneke, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dgtndn189tdgrk5icdj6g6md1e